» Articles » PMID: 16121805

Proteomic Analysis of Urinary Protein Markers for Accurate Prediction of Diabetic Kidney Disorder

Overview
Specialty General Medicine
Date 2005 Aug 27
PMID 16121805
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Aim Of The Study: Microalbuminuria is currently the only diagnostic tool available for early diagnosis of diabetic nephropathy. The test is based on immunological detection of small quantities of albumin in the urinary samples of diabetes patients. There are several limitations of the use of microalbuminuria as an index of renal function. It is therefore desirable to identify additional protein markers that would augment prediction of diabetic nephropathy. The aim of this study is to identify urinary protein markers for specific and more accurate prediction of nephropathy in diabetes patients.

Design: 100 registered Type II diabetic patients were studied. Abundant proteins of microalbuminuria positive urinary samples of these patients were analyzed by proteomics approaches of 2-Dimentional Gel Electrophoresis (2DGE) and mass spectrometry.

Results: 2-DGE analysis of the urine sample revealed four main proteins along with albumin in these samples. These were zinc alpha-2 glycoprotein, alpha-1 acid glycoprotein, alpha-1 microglobulin and IgG as identified by Matrix Assisted Laser Desorption Ionization-Tune of Flight (MALDI-ToF) and by western blot. Twenty control samples and three cases with microalbuminuria negative to positive transition does suggest the early and co-appearance of the markers with albumin. We have also analyzed full length spectrum of these samples by MALDI-ToF.

Conclusion: Our study shows the presence of additional proteins in urine samples of microalbuminuria positive diabetes patients. These proteins can be used as markers for specific and accurate clinical analysis of Diabetic nephropathy. We propose a mass spectrometry based high throughput diagnostic approach to detect these markers in the urine sample.

Citing Articles

Early Detection of Diabetic Nephropathy Based on Urinary and Serum Biomarkers: An Updated Systematic Review.

Karimi F, Moazamfard M, Taghvaeefar R, Sohrabipour S, Dehghani A, Azizi R Adv Biomed Res. 2024; 13:104.

PMID: 39717256 PMC: 11665175. DOI: 10.4103/abr.abr_461_23.


Adiponectin Can Be an Early Predictable Marker for Type 2 Diabetes Mellitus and Nephropathy.

Ganesh V, M M, Palem S Cureus. 2022; 14(7):e27308.

PMID: 36039271 PMC: 9403389. DOI: 10.7759/cureus.27308.


Identification of Novel Biomarker for Early Detection of Diabetic Nephropathy.

Kim K, Lee J, Park J, Lee E, Moon J, Lee S Biomedicines. 2021; 9(5).

PMID: 33922243 PMC: 8146473. DOI: 10.3390/biomedicines9050457.


Association of neutrophil-gelatinase-associated lipocalin with microvascular complications in patients with type 2 diabetes: a cross-sectional study.

Aslanhan E, Ojalvo D, Ozsenel E, Basat S, Borlu F Cardiovasc Endocrinol Metab. 2019; 8(3):82-87.

PMID: 31646302 PMC: 6779845. DOI: 10.1097/XCE.0000000000000180.


Characterization of low molecular weight urinary proteins at varying time intervals in type 2 diabetes mellitus and diabetic nephropathy patients.

Patel D, Kalia K Diabetol Metab Syndr. 2019; 11:39.

PMID: 31131043 PMC: 6525442. DOI: 10.1186/s13098-019-0430-1.